Application of machine learning in predicting hospital readmissions: a scoping review of the literature Y Huang, A Talwar, S Chatterjee, RR Aparasu BMC medical research methodology 21, 1-14, 2021 | 71 | 2021 |
Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis A Talwar, E Estes, R Aparasu, DS Reddy Experimental Neurology 359, 114238, 2023 | 25 | 2023 |
Fondaparinux Sodium Compared With Low‐Molecular‐Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta‐analysis A Kumar, A Talwar, JF Farley, J Muzumdar, JC Schommer, R Balkrishnan, ... Journal of the American Heart Association 8 (10), e012184, 2019 | 22 | 2019 |
Anticholinergic medications and risk of dementia in older adults: where are we now? S Chatterjee, A Talwar, RR Aparasu Expert Opinion on Drug Safety 19 (10), 1251-1267, 2020 | 20 | 2020 |
Machine learning methods to predict 30-day hospital readmission outcome among US adults with pneumonia: analysis of the national readmission database Y Huang, A Talwar, Y Lin, RR Aparasu BMC Medical Informatics and Decision Making 22 (1), 288, 2022 | 4 | 2022 |
Pain management practices for outpatients with breast cancer A Talwar, S Rege, RR Aparasu Exploratory Research in Clinical and Social Pharmacy 6, 100155, 2022 | 4 | 2022 |
Prescribing of disease modifying agents in older adults with multiple sclerosis A Talwar, JR Earla, GJ Hutton, RR Aparasu Multiple Sclerosis and Related Disorders 57, 103308, 2022 | 4 | 2022 |
Performance of advanced machine learning algorithms overlogistic regression in predicting hospital readmissions: A meta-analysis A Talwar, MA Lopez-Olivo, Y Huang, L Ying, RR Aparasu Exploratory Research in Clinical and Social Pharmacy 11, 100317, 2023 | 2 | 2023 |
Differences in perceived threat and efficacy in managing opioid use disorder versus alcohol use disorder V Tata, Z Majd, A Talwar, S Bapat, ADL Cruz, JE Essien, JD Thornton Substance Use & Misuse 58 (10), 1187-1195, 2023 | 2 | 2023 |
PSU20 Predicting Readmissions for Elective Hip and Knee Arthroplasty in Adults using Machine Learning Algorithms A Talwar, Y Huang, Y Lin, P Masurkar, RR Aparasu Value in Health 24, S227-S228, 2021 | 1 | 2021 |
Pdg44 drug information on the internet-consistently inconsistent results: content analysis using three major search engines Z Majd, A Talwar, SS Sansgiry Value in Health 22, S169-S170, 2019 | 1 | 2019 |
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer’s Disease Initiating Cholinesterase Inhibitors A Talwar, S Chatterjee, J Sherer, S Abughosh, M Johnson, RR Aparasu Drugs & Aging 41 (4), 339-355, 2024 | | 2024 |
CUMULATIVE ANTICHOLINERGIC BURDEN AND ASSOCIATED OUTCOMES AMONG OLDER ADULTS WITH ALZHEIMER’S DISEASE A TALWAR | | 2024 |
EE483 Health Care Expenditures for Substance Use Disorders: A Comparative National Study Z Zeng, A Talwar, RR Aparasu Value in Health 26 (6), S147-S148, 2023 | | 2023 |
EE496 Comparative Healthcare Burden for Colorectal Cancer and Other Cancers: Medical Expenditure Panel Survey Study S Yazdanfard, A Talwar, RR Aparasu Value in Health 26 (6), S150, 2023 | | 2023 |
CO203 Cumulative Anticholinergic Burden and Its Predictors Among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors A Talwar, JT Sherer, S Abughosh, S Chatterjee, ML Johnson, RR Aparasu Value in Health 26 (6), S53, 2023 | | 2023 |
Cost-effectiveness analysis of abemaciclib and endocrine therapy combination for the adjuvant treatment of HR+/HER2-, node-positive, high-risk, early breast cancer A Talwar, A Deshmukh, M Trivedi, RR Aparasu Cancer Research 83 (7_Supplement), 4364-4364, 2023 | | 2023 |
Anticholinergic medications and risk of dementia in older adults: A meta-analysis of recent literature A Talwar, S Chatterjee, MA Lopez-Olivo, RR Aparasu Research in Social and Administrative Pharmacy 19 (3), 3, 2023 | | 2023 |
EPH110 Endocrine Therapy and Risk of Dementia in Patients with Breast Cancer: A Systematic Review BL Christensen, A Talwar, RR Aparasu Value in Health 25 (7), S455, 2022 | | 2022 |
Factors associated with different dosage forms of disease-modifying agents in older adults with multiple sclerosis A Talwar, JR Earla, GJ Hutton, RR Aparasu PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 30, 228-228, 2021 | | 2021 |